From Access to Monitoring:

25 Years Forward for Every CML Patient

Chronic Myeloid Leukemia (CML) is a condition that demands our attention and compassion. This year we’re coming together with the theme From Access to Monitoring: 25 Years Forward for Every CML Patient. Our mission is simple: make sure every CML patient, wherever they are, has equal access to diagnosis, treatment, and support. Let’s take action and ensure no one is left behind.

This year marks 25 years since the first targeted therapy transformed CML from a fatal diagnosis into a manageable condition.

Yet in 2026, too many patients still face barriers to treatment, diagnostics, and regular monitoring.
Progress is not progress unless it reaches everyone.

On World CML Day 2026, we unite to ensure that access to treatment, access to monitoring, and patient-centered care are not privileges — but standards.

Because 25 years of progress must mean leaving no CML patient behind.

This is your moment to reflect, celebrate, and share. So, we ask you to join us as we unite for #WCMLD26 and tell us: What does equal access to CML care look like in your country? and What barriers still prevent CML patients from accessing the care they need? Let your voice be heard!

The latest

VIDEOS

Put a spotlight on CML by describing how you cope with the challenges of a CML diagnosis and what it is like to navigate today’s world after your diagnosis.